Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
4450 Cousens , Montreal, QC, H4S 1X6, CA
Groupe PARIMA is a leading CDMO specializing in non-sterile liquids, suspensions, and semi-solid pharmaceutical products. Our team of scientific experts provides comprehensive CMC services, including turn-key formulation development, clinical material production, and commercial manufacturing. With regulatory expertise for FDA, EMA, and Health Canada, we serve over 45 markets, delivering tailored solutions and fostering long-term partnerships. Our advanced capabilities include analytical testing, process optimization, and scale-up services, ensuring innovative, high-quality solutions across various therapeutic areas.
For this roundtable, Contract Pharma called upon thought leaders across the pharmaceutical services sector to address “3 Key Trends” impacting the CDMO industry in 2025 and beyond.
By: Tim Wright
The CEO of Woodstock Sterile Solutions discusses strategic investments, blow-fill-seal leadership, and building a future-ready CDMO.
Plan includes expanding the site, installing a new filling line, and upgrading existing equipment to comply with new Health Canada standards.
By: Charlie Sternberg
A conversation with the CEO and president of JHS about the company's continued growth and the emerging trends shaping the CDMO landscape.
Released By Jubilant HollisterStier CMO
Catalyst will supply the product to Kye, which will assume full responsibility for obtaining regulatory approval for the novel corticosteroid.
The approval follows an inspection by the cell and gene therapy experts from Health Canada.
CPL represents Aterian’s thirteenth investment in the life sciences.
By: Kristin Brooks
Will work alongside CPL’s stakeholders on the company’s next stage of growth.
BioVectra's CSO talks about the LNP partnership with Acuitas Therapeutics and how the CDMO's new biomanufacturing center enhances it capabilities.
By: Marc Sauer
Canada springs into action after FDA approves Florida’s plan to import drugs from our neighbors in the North.
By: Bob Pollock
A blog exploring the regulatory issues impacting the pharma industry with the experts at Lachman Consultants.
By: Patrick Day,
Cross-agency cooperation takes next step in artificial intelligence maturity.
Regulatory agencies are adapting to the digital age by implementing processes and documentation enabled by modern technology.
By: Rama Mohan
Development and submission of labels and regulatory filings to support compliance with new FDA & Health Canada Standards.
How Canada’s 30-day regulatory review process could provide an advantage.
By: Roland Jbeily
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
